September Slide, Vaccine Optimism & Stimulus Talks Back On Table
Jim Cramer and David Faber discuss Wall Street’s tough September, stocks on pace for their fourth straight weekly loss, for the first time in more than a year. Plus signs of hope for a COVID-19 vaccine, Novavax starting a phase 3 trial & Sanofi predicting one billion doses produced globally by early next year. And House Democrats preparing a new $2.4 trillion stimulus plan with unemployment aid, direct payments.
Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Jim Cramer and David Faber discuss Wall Street’s tough September, stocks on pace for their fourth straight weekly loss, for the first time in more than a year. Plus signs of hope for a COVID-19 vaccine, Novavax starting a phase 3 trial & Sanofi predicting one billion doses produced globally by early next year. And House Democrats preparing a new $2.4 trillion stimulus plan with unemployment aid, direct payments.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.